Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Epilepsy × Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 212 Breast Neoplasms 173 Glioblastoma 172 Lung Neoplasms 171 Head and Neck Neoplasms 150 Prostatic Neoplasms 139 Lymphoma 135 Squamous Cell Carcinoma of Head and Neck 130 Rectal Neoplasms 115 Central Nervous System Neoplasms 101 Leukemia 97 Esophageal Neoplasms 95 Precursor Cell Lymphoblastic Leukemia-Lymphoma 83 Brain Neoplasms 83 Pancreatic Neoplasms 82 Gliosarcoma 79 Lymphoma, Follicular 70 Esophageal Squamous Cell Carcinoma 70 Lymphoma, Large B-Cell, Diffuse 68 Lymphoma, Non-Hodgkin 66 Hodgkin Disease 65 Sarcoma 64 Uterine Cervical Neoplasms 62 Burkitt Lymphoma 59 Neoplasms 57 Leukemia, Lymphocytic, Chronic, B-Cell 56 Colorectal Neoplasms 55 Lymphoma, Large-Cell, Immunoblastic 52 Glioma 52 Astrocytoma 49

Interventions

Sirolimus 4 LY3295668 erbumine 3 Everolimus 3 Anticonvulsants 2 perampanel 1 clevidipine 1 brivaracetam 1 Vigabatrin 1 Topotecan 1 Therapeutic Touch 1 Temozolomide 1 TAS-119 1 Sulfasalazine 1 Sevoflurane 1 Saline Solution 1 Radiotherapy 1 Propofol 1 Paclitaxel 1 Nitrous Oxide 1 Midazolam 1 Memantine 1 Medical Marijuana 1 Lidocaine 1 Levetiracetam 1 Ketamine 1 Immunoglobulins, Intravenous 1 Glycopyrrolate 1 Gabapentin 1 Fluid Therapy 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05664464 2024-05-10

GLUGLIO

University of Zurich

Phase 1/2 Recruiting

Epilepsy, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡